- Home
- NYMT vs BCYC Comparison
NYMT vs BCYC Comparison
Compare NYMT & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMT
- BCYC
- Stock Information
- Founded
- NYMT 2003
- BCYC 2009
- Country
- NYMT United States
- BCYC United Kingdom
- Employees
- NYMT N/A
- BCYC N/A
- Industry
- NYMT Real Estate Investment Trusts
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- NYMT Real Estate
- BCYC Health Care
- Exchange
- NYMT Nasdaq
- BCYC Nasdaq
- Market Cap
- NYMT 583.3M
- BCYC 566.5M
- IPO Year
- NYMT 2004
- BCYC 2019
- Fundamental
- Price
- NYMT $6.58
- BCYC $7.99
- Analyst Decision
- NYMT Strong Buy
- BCYC Buy
- Analyst Count
- NYMT 5
- BCYC 11
- Target Price
- NYMT $7.81
- BCYC $25.00
- AVG Volume (30 Days)
- NYMT 697.6K
- BCYC 277.2K
- Earning Date
- NYMT 07-30-2025
- BCYC 08-12-2025
- Dividend Yield
- NYMT 12.16%
- BCYC N/A
- EPS Growth
- NYMT N/A
- BCYC N/A
- EPS
- NYMT 0.19
- BCYC N/A
- Revenue
- NYMT $208,943,000.00
- BCYC $25,722,000.00
- Revenue This Year
- NYMT $6.23
- BCYC $7.35
- Revenue Next Year
- NYMT $12.09
- BCYC N/A
- P/E Ratio
- NYMT $34.27
- BCYC N/A
- Revenue Growth
- NYMT 25.40
- BCYC N/A
- 52 Week Low
- NYMT $5.02
- BCYC $6.10
- 52 Week High
- NYMT $7.27
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- NYMT 45.20
- BCYC 46.46
- Support Level
- NYMT $6.16
- BCYC $8.40
- Resistance Level
- NYMT $6.94
- BCYC $8.88
- Average True Range (ATR)
- NYMT 0.19
- BCYC 0.50
- MACD
- NYMT -0.04
- BCYC -0.00
- Stochastic Oscillator
- NYMT 46.15
- BCYC 24.40
About NYMT New York Mortgage Trust Inc.
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets. Geographically operates in USA states California, New York, Florida, New Jersey, Illinois, maximum from California.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.